ERIC DOBMEIER - 01 Dec 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
01 Dec 2022
Net transactions value
-$644,151
Form type
4
Filing time
02 Dec 2022, 15:26:37 UTC
Previous filing
11 Oct 2022
Next filing
15 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KDNY Common Stock Gift $0 -25,000 -11% $0.000000 211,676 01 Dec 2022 Direct
transaction KDNY Common Stock Options Exercise $25,200 +60,000 +28% $0.4200* 271,676 01 Dec 2022 Direct
transaction KDNY Common Stock Sale $669,351 -30,000 -11% $22.31 241,676 01 Dec 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Stock Option (Right to Buy) Options Exercise $0 -60,000 -14% $0.000000 363,555 01 Dec 2022 Common Stock 60,000 $0.4200 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.08 to $22.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
F3 The stock option vested as to 25% of the total shares monthly on March 6, 2021, and thereafter vests as to 1/48 of the total shares until fully vested, subject to the Reporting Person's provision of service to the Issuer on the vesting date.